Recent Company News

• 10:08 PM ET Dec 12, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 05:36 PM ET Dec 10, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:18 AM ET Dec 11, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:55 AM ET Dec 11, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:24 AM ET Dec 11, 2025
  

  StreetAccount Summary - US Pre-market trading

• 07:02 AM ET Dec 11, 2025
  

  Centessa Pharmaceuticals announces CEO transition ($29.57, 0.00)

• 06:59 AM ET Dec 11, 2025
  

  Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications

• 08:21 AM ET Dec 10, 2025
  

  Centessa Pharmaceuticals assumed outperform at Oppenheimer ($28.60, 0.00)

• 10:04 AM ET Dec 08, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (173 total)